Page last updated: 2024-12-08

kinetensin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

kinetensin: nonapeptide with neurotensin-like immunoreactivity; isolated from pepsin-treated human plasma [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

kinetensin : An oligopeptide comprising of nine amino acids with sequence L-Ile-L-Ala-L-Arg-L-Arg-L-His-L-Pro-L-Tyr-L-Phe-L-Leu. It was originally isolated from pepsin-treated human plasma and shares some sequence homology with the C-terminal end of neurotensin. It is a potent histamine releaser and may serve as an inflammatory mediator. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID147043
CHEBI ID80144
MeSH IDM0140236

Synonyms (17)

Synonym
kinetensin
103131-69-7
ile-ala-arg-arg-his-pro-tyr-phe-leu
kinetensin (human)
AKOS024456852
DTXSID00145667
mfcd00167613
J-000882
h-ile-ala-arg-arg-his-pro-tyr-phe-leu-oh
HY-P1255
CS-0029130
MS-32027
l-ile-l-ala-l-arg-l-arg-l-his-l-pro-l-tyr-l-phe-l-leu
iarrhpyfl
i-a-r-r-h-p-y-f-l
CHEBI:80144
l-isoleucyl-l-alanyl-l-arginyl-l-arginyl-l-histidyl-l-prolyl-l-tyrosyl-l-phenylalanyl-l-leucine

Research Excerpts

Overview

Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma. It shares some sequence homology with the C-terminal end of neurotensin.

ExcerptReferenceRelevance
"Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma, that shares some sequence homology with the C-terminal end of neurotensin. "( Pharmacokinetics and biological activity of kinetensin in conscious sheep.
Fletcher, D; Hardy, K; Read, D; Shulkes, A, 1993
)
1.99
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
histamine releasing agentAny substance that can induce the release of histamine from mast cells.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
oligopeptideA peptide containing a relatively small number of amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (16.67)18.7374
1990's3 (16.67)18.2507
2000's7 (38.89)29.6817
2010's5 (27.78)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.79 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]